ACST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases...

Stats
Dzisiejszy wolumen	15 084.00
Średni wolumen	23 153.00
Kapitalizacja rynkowa	25.28M
EPS	$-0.300 ( 2024-02-13 )
Następna data zysków	( $-0.350 ) 2024-06-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.470
ATR14	$0.0500 (1.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-06	D'andrea Carrie	Buy	19 740	Stock Options (Right to Buy)
2024-05-06	Kumar Amresh	Buy	19 740	Stock Options (Right to Buy)
2024-05-06	Macdonald R. Loch	Buy	25 380	Stock Options (Right to Buy)
2024-05-06	Delaversano Robert J	Buy	4 500	Stock Options (Right to Buy)
2024-05-06	Kohli Prashant	Buy	128 770	Stock Options (Right to Buy)

INSIDER POWER
90.42
Last 69 transactions
Buy: 4 450 516 \| Sell: 2 858 533

Acasti Pharma Inc Korelacja

10 Najbardziej pozytywne korelacje
SONO	0.881
NNDM	0.881
MTRX	0.867
ULCC	0.866
CFLT	0.865
ALRM	0.863
EQ	0.854
TRMB	0.853
QQQN	0.849
LSCC	0.849

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acasti Pharma Inc Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$-52.16M (0.00 %)
EPS:	$-5.71

FY	2022
Przychody:	$0
Zysk brutto:	$-52.16M (0.00 %)
EPS:	$-5.71

FY	2022
Przychody:	$0
Zysk brutto:	$-15.59M (0.00 %)
EPS:	$-0.270

FY	2021
Przychody:	$196 000
Zysk brutto:	$120 000 (61.22 %)
EPS:	$-1.360

Financial Reports:

No articles found.

Acasti Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.